Bone proteins costly in surgery, study says
Wall Street Journal, July 1, 2009
The use in spine surgery of bone-growth proteins has led to widespread nationwide increases in hospital charges ranging from 11% to 41% above conventional surgical costs, researchers found. The researchers studied the results of a broad U.S. sample of 328,000 spine surgeries from 2002 through 2006. The authors, from both Brigham & Women's Hospital in Boston and from Yale, also found that by 2006 the use of the new bone proteins had increased to nearly 25% of all operations in which spinal vertebrae are fused together to alleviate back pain.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- Carondelet to Pay $35M to Settle Fraud Allegations
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- 3 Traits Personality Assessments Can't Reveal
- CA Powers Up $80M HIE to 'Create Value in the Data'